Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) |
| Clone | [3D3] |
| Host Species | Mouse |
| Reactive Species | human, rabbit, rat |
| Isotype | IgG1 |
| Format | unconjugated |
| Size | 0.02 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (Without BSA & Azide at 1mg/ml) |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Immunofluorescence (IF), Immunoprecipitation (IP), Western Blot (WB), Immunohistochemistry (IHC) Formalin |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Podocalyxin is a member of the CD34 transmembrane sialomucin family. It is over-expressed on the podocyte foot projections and plays essential roles in kidney development and homeostasis, blood filtration and urine formation. It is also expressed on vascular endothelia, hematopoietic progenitors and a subset of neurons. Overexpression of podocalyxin may be linked to more aggressive tumor behavior. Podocalyxin antibody can identify podocytes in the urine (podocyturia) that may indicate glomerular disease, pre-eclampsia, and other kidney pathology. |
| Immunogen | Immunogen: A recombinant protein fragment containing the intracellular, transmembrane, and part of the extracellular domain of human podocalyxin |
| Other Names | [PODXL, PDXL, GCTM-2; Gp200; PCLP1; Pcx; Podocalyxin-like protein 1], [PODXL; PODXL; PC; PCLP; Gp200; PCLP-1; PCLP; PCLP1; PC; PCLP-1] |
| Gene, Accession # | [PODXL], Gene ID: 5420, NCBI: NP_001018121.1, UniProt: O00592 |
| Catalog # | MBS438263 |
| Price | $190, $340, $340 |
| Order / More Info | Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Kershaw DB et. al. J Biol Chem 272:15708-15714 (1997). Sassetti C et. al. J Exp Med 187:1965-1975. 3. Nielsen JS et. al. J Am Soc Nephrol 20:1669-1676 (2009). |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies